🧬 Genetic Testing in Uveal Melanoma: Advancements & Challenges 🚀 In this video, Dr. Moser and Dr. Ulrich dive into the fascinating world of genetic testing 🔍 for uveal melanoma, a rare and complex cancer. 🎗️ They break down cutting-edge topics like somatic testing, liquid biopsies, and whole exome sequencing, offering valuable insights for patients and caregivers alike. ✨ What you’ll learn: ✅ The difference between tissue biopsies and liquid biopsies 🩸 ✅ How genetic mutations like GNAQ and GNA11 impact treatment 🧠 ✅ Why whole exome sequencing offers a comprehensive view 🧬 ✅ Tips on navigating genetic reports and advocating for better care 💪 ✅ The role of genetic data in shaping personalized cancer treatment 🔑 This session is packed with easy-to-understand analogies 🏡, expert insights, and hope for the future of uveal melanoma care. 🌟 Looking for a Cure? Join our free webinar or connect with our community at A Cure In Sight to learn more about how we support ocular melanoma patients and their families. 💙 https://s.mtrbio.com/LookingforACure 📢 Don’t forget: 👍 Like this video 💬 Comment below 🔔 Subscribe for more updates on uveal melanoma research, breakthroughs, and resources! 📚 Chapters 0:00 - 👋 Introduction of Dr. Moser and Dr. Ulrich 1:15 - 🧬 What is Somatic Testing? Overview and Key Concepts 5:00 - 🩸 Liquid Biopsies vs. Tissue Biopsies: Pros and Cons 10:30 - 🔍 Sensitivity and Limitations of Genetic Testing in Uveal Melanoma 15:45 - 🧠 Whole Exome vs. Hotspot Panels: What’s the Difference? 20:00 - 🔑 Importance of Comprehensive Testing for Rare Cancers 25:10 - 🎗️ Key Genetic Mutations in Uveal Melanoma (GNAQ, GNA11, BAP1) 30:00 - 🚀 The Future of Genetic Testing: Clinical Trials and New Therapies 35:10 - 💪 Practical Advice on Genetic Reports and Patient Advocacy 40:00 - ❓ Q&A: Liquid Biopsies, Financial Concerns, and Patient Support